Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1.38M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
426K
-
Shares change
-
-54.5K
-
Total reported value, excl. options
-
$262K
-
Value change
-
-$39.9K
-
Number of buys
-
7
-
Number of sells
-
-3
-
Price
-
$0.61
Significant Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q4 2022
11 filings reported holding KZIA - KAZIA THERAPEUTICS LTD - American Depository Shares as of Q4 2022.
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 426K shares
of 1.38M outstanding shares and own 30.92% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (257K shares), ACADIAN ASSET MANAGEMENT LLC (104K shares), OLD MISSION CAPITAL LLC (42.8K shares), TWO SIGMA SECURITIES, LLC (12.2K shares), UBS Group AG (6.35K shares), Belpointe Asset Management LLC (3K shares), WELLS FARGO & COMPANY/MN (200 shares), Steward Partners Investment Advisory, LLC (75 shares), AdvisorNet Financial, Inc (5 shares), and Virtu Financial LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.